Ketamine Providers in Oregon
20 providers across 10 cities
Oregon has 20 ketamine therapy providers across 10 cities. The most common provider types are wellness & integrative center, ketamine infusion clinic, psychiatry practice. Providers in Oregon commonly treat depression, anxiety, ptsd. Top cities include Portland, Corvallis, Eugene, Beaverton, Clackamas.
Ketamine Therapy in Oregon
Oregon stands at the forefront of innovative mental health treatment, being the first state to legalize psilocybin therapy while maintaining a thriving ketamine therapy landscape. Our directory features 27 ketamine therapy providers across Oregon, with a concentration of clinics in the Portland metro area offering IV infusions, intramuscular injections, and at-home oral protocols. Whether you're exploring ketamine for treatment-resistant depression, anxiety, PTSD, or chronic pain, these Oregon providers deliver supervised, evidence-based care in one of the nation's most progressive therapeutic environments.
Oregon ranks 11th nationally with 20 ketamine therapy providers, averaging 2 providers per city. The largest provider category is wellness & integrative center (30% of providers). Portland leads the state with 9 providers.
State Regulations
Oregon regulates ketamine as a Schedule III controlled substance under federal DEA rules, requiring a valid DEA registration to prescribe. The state has no ketamine-specific clinic licensing or adverse event reporting requirements. Oregon's progressive therapeutic culture, shaped by its pioneering Measure 109 psilocybin framework, has fostered a receptive environment for ketamine therapy, particularly in the Portland metro area.
Insurance & Medicaid Coverage
Oregon Health Plan (Medicaid) covers Spravato (esketamine) for treatment-resistant depression and MDD with acute suicidal ideation, but requires prior authorization through OHA fee-for-service. Patients must have tried at least two antidepressants with inadequate response, be engaged in psychotherapy, and be under 65. Initial approval covers a 28-day induction phase, with renewals up to 6 months.
Telehealth Options
Oregon follows federal DEA telemedicine rules for controlled substances. Under extended COVID-era flexibilities, practitioners can prescribe Schedule II-V substances via telehealth without a prior in-person visit. Oregon has no additional state-level restrictions on telehealth ketamine prescribing beyond standard DEA requirements.
Cost of Ketamine Therapy
IV ketamine infusions in Oregon typically cost $450–$800 per session. Portland metro clinics range from $465-$688 per IV session. Oregon's competitive market with multiple providers keeps pricing near national averages. A standard initial series of 6 infusions runs $2700–$4200. Spravato (esketamine) may be partially or fully covered by insurance.
Mental Health Access
Oregon meets only 30.02% of its mental health care needs according to HRSA data. The state needs an estimated 68 additional mental health practitioners to remove all HPSA designations, with rural and eastern Oregon counties most severely affected. Oregon has approximately 0.64 ketamine providers per 100,000 residents.
Frequently Asked Questions
- Yes, ketamine therapy is fully legal in Oregon when prescribed by a licensed practitioner with DEA registration. It is used off-label for depression, anxiety, PTSD, and chronic pain. Oregon has no specific state laws restricting ketamine clinics, though providers must follow federal controlled substance regulations and standard medical practice guidelines.
- Oregon Health Plan covers FDA-approved Spravato (esketamine nasal spray) for treatment-resistant depression with prior authorization through OHA. Patients must have failed at least two antidepressants and be engaged in psychotherapy. Off-label IV ketamine is generally not covered by OHP.
- Oregon's Measure 109 psilocybin program has increased public awareness and acceptance of psychedelic-assisted therapies statewide. While psilocybin and ketamine are regulated separately, the progressive therapeutic environment in Oregon has attracted more ketamine providers, particularly in Portland, giving patients broader access to innovative mental health treatments.